ALK5-IN-28
ALK5-IN-28 (compound Ex-05) is a selective ALK-5 inhibitor (IC50≤10 nM), inhibits TGF-β-induced SMAD signaling. ALK5-IN-28 has the potential to inhibit growth of tumour in vivo. ALK5-IN-28 can be used in study of proliferative diseases such as cancer, fibrotic diseases, and systemic sclerosis[1].
Product Specifications
CAS Number
2785430-84-2
UNSPSC
12352005
Target
TGF-beta/Smad; TGF-β Receptor
Type
Reference compound
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/alk5-in-28.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=CC2=C(NC3=NC(NC4=CC=C(CC5CCNCC5)C=C4)=NC=C3)C=NN=C12
Molecular Formula
C25H27N7
Molecular Weight
425.53
References & Citations
[1]Bettina FRANZ, et al. Alk-5 inhibitors and uses thereof. Patent WO2022126133A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ALK5
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC741628-500 1x 500 µL
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (UCHT4), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470326-500 1x 500 µL
Serum Amyloid A (SAA/326), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
